InvestorsHub Logo
Followers 2
Posts 219
Boards Moderated 0
Alias Born 03/19/2013

Re: HDGabor post# 32653

Friday, 08/22/2014 10:08:28 AM

Friday, August 22, 2014 10:08:28 AM

Post# of 423960
HD...

While I commend your theories, (very thought out, detailed and provocative) I ask you again...what is the stock telling us??

Look, since approval many have taken small pieces and believed that they were all pieces to a grand puzzle that was going to lead shareholders to a land of prosperity, (BO, NCE, ADCOM, ANCHOR etc etc) yet the stock has done nothing but COLLAPSE, having lost 80%-90% since Vascepa approval over two years ago. Think about that for a second. 80-90% since approval. During that time, the stock price action has been dead right in predicting what was to come for this company. GIA. NCE Delay. Dilution. ADCOM fiasco. No NCE. Appeal denials (delays). Additionally, during that time the growth of Vascepa has been anemic, at best. As a battered, left for dead, biotech company that has an approved, safe drug with potential revenues into the billions, one would expect that the stock price would have firmed up by now, and built back some considering how much they have going for them, at least according to many on this board.

Is the stock telling us (you) that JJ is leaning towards granting an appeal, or that this shelf cloak and dagger nonsense is really a clue that something is going on behind the scenes??
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News